Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room - Acquisitions and disposals of own shares

INFORMATION REGLEMENTEE


[10/08/2020 | 08:02]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6enPgwI16r40kJldvOc0ErQ78rneP03-2BfZCVOLA5HFfsWTmkMmO-2F=
KbSX3zYAc25GzyGZcBLjrv-2FIEgvR7PihjFZJx9a-_xDPID0vOuylFAU8fv4e60wei4JxqEGBd=
VWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9=
c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZ=
KHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfBFI1nkExHc-2BxDQPJU7JbJwVQU9a7xBz=
COfFPoHN6ld-2BssbCvgjSfbU08mX17x68Gtgd7mTKpTzjmku-2FoDff7Dl-2BEfpOcAqUOGMYS=
Z8xUn7WXlnu-2FgoeZ7urLUylRU-2BCkaAbrxdpSxCgsIgmWLp2R84WeI-2F8-3D

** Acquisitions and disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 10=C2=A0August 2020 =E2=80=93 08:00 (CEST) =E2=80=93 re=
gulated information

Acquisitions of own shares

In accordance with article 8:4 of the Royal Decree of 29 April 2019 executi=
ng the Belgian Code on Companies and Associations, UCB=C2=A0SA/NV (=E2=80=
=9CUCB=E2=80=9D or the =E2=80=9CCompany) (Euronext Brussels: UCB) hereby di=
scloses certain information in relation to its Share Repurchase Program 202=
0.

Under this program, UCB has requested a financial intermediary to repurchas=
e up to 1.2 million UCB shares on its behalf under the terms of a discretio=
nary mandate agreement with initial validity until 15 June 2020, effective =
as from 25 March 2020, to cover current and future obligations under UCB's =
Long Term Incentive Plans for its personnel. The validity of this agreement=
has been extended to 30 September 2020.

In the framework of this Share Repurchase Program 2020, UCB repurchased 178=
242 UCB shares on Euronext Brussels in the period from 31 July 2020 up to =
and including 5 August 2020, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6enPgwI16r40kJldvOc0ErQ7HXE7UJlIcuwP2EroU4xBOraJckxctKua=
dhr6h5JGA-2BDYPpZ0tZU5PJ-2B5bzgQKQ3lq5x1_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKH=
CeAb2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfBFI1nqwHPJmQOtinrnSk6B6ms-2BFXurGpx=
cnRBGoHXOE4phtR98Lk86hGoU0i5CEfrysyR-2Fi9wAGf4V1-2BoGQ5wPMtWN2uVBdWqEJa-2FO=
F15-2BnAplJOP-2Fcu6fOFe1dCfUcBXEewKAU8ISUm4LlGJg-2FMDp8bTMc-3D

As a result thereof, the Share Repurchase Program 2020 has been completed.
=C2=A0
Disposals of own shares
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB=C2=A0announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6enPgwI16r40kJldvOc0ErQ7rSATNNZNPf1RczKSFKxGKri0shVKlLtW=
0pgVJmOG75oZvbTY95MUah-2Fs1zdfjp0NGghV_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7=
KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1=
waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCe=
Ab2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfBFI1nueGOk-2FBzO8ho3Lxklj-2Fj3Fm5hqzQ=
yy8-2BZb14LojH3TvzG56fz4XbgquBsNmkxcf-2BWz5xSI5wRPc96TKkrSHCIrv3pUTWeEMYU2Y=
lb-2BXgZ6zsiEbkQ3aLbDYElMnsyUroKpDg6LB2gGSMcDvKqCBQhk-3D

This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the=
following link. (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM=
8iDZJQyQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSz=
xYKNx18dK5MiuQ-3D-3DRAOV_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46=
DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG=
1KVL4B2sVAUtj5-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO=
5xZnqqucr5Jk4LjF-2FvwnJfBFI1ntqsQqMdQkExu4gPa5Viice-2F2XGRMf4EvqFgTwiemHwL0=
hvyz5feFWtcV9PfMXGOwyL0QiW9Z6iZG4FX-2FRUT1VPqcD4W9q2saYiawDnjxM5SR-2BKBHHSW=
-2FYO1MLTRUMnqYdL-2BUJXLclRKMZd170X82RE-3D
=C2=A0
Investor relations

Antje Witte
Investor Relations, UCB
T +32 2 559 94 14
antje.witte@ucb.com

Isabelle Ghellynck
Investor Relations, UCB
T +32 2 559 95 88
isabelle.ghellynck@ucb.com
=C2=A0
About UCB

UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/ls/cl=
ick?upn=3DTeZUXWpUv-2B6TCY38pVLo9rKKs1SKiGimp-2BflGZwlYo0-3Dn90M_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdylaG89YV7aj8m=
VMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfBFI1nuigaSf=
bLY2xnjoVJSkzuIrj9Xa4I-2Bg5UOuSotOwf4aXQeY-2BtN6V8F5ZEz9LYS8bAdYkNZKtDV9uzF=
lA7mzWxANfBew8vbyohbueaWfnj3HowDAJkGnntF22DtMRpxvhxZjhxDI1JsYFMv202wuESQo-3=
D ) is a global biopharmaceutical company focused on the discovery and deve=
lopment of innovative medicines and solutions to transform the lives of peo=
ple living with severe diseases of the immune system or of the central nerv=
ous system. With 7 500 people in approximately 40 countries, the company ge=
nerated revenue of =E2=82=AC 4.9 billion in 2019. UCB is listed on Euronext=
Brussels (symbol: UCB). Follow us on Twitter: @UCB_news

Image
Chart 1 Acquisitions and disposals of own shares August 10 2020 (https://u7=
061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ=
-2Fb7C-2B6enPgwI16r40kJldvOc0ErQ7HXE7UJlIcuwP2EroU4xBOpwR6Klwb0cRzKS-2FZJKe=
ZTY-3D-1XJ_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6=
EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5=
-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4L=
jF-2FvwnJfBFI1nrOjeX3Bb2u-2F9hPz1pv6IPz6JADBltZVg2G0Xpt3Oztt0eXzz9OmNTrwDc5=
COB5uC0e6mwfoix-2B42RSO1ElmCWBrKrhROBWVApL3o9ogUwWhil9i9CSZqCNDXbtG6z8rOKZu=
ism-2BMBeqfEtfhJ0wTlQ-3D Image
Chart 2 Acquisitions and disposals of own shares August 10 2020 (https://u7=
061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ=
-2Fb7C-2B6enPgwI16r40kJldvOc0ErQ7rSATNNZNPf1RczKSFKxGKp-2F87xmmyxtw0xGTDrqU=
Aik-3DEuoy_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6=
EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5=
-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4L=
jF-2FvwnJfBFI1nhTtjpc3DTxY7oPtnuOva8-2Fbl0ZlLXA03oCyUB8e5jn22aVjEQItks28W2s=
oha7yFn4Rah6qFjlcM5v0jx77Yn5Vw1zV4-2FEFPmLyajgxNrE6pNdXg9WcYibhyRxPo8Eez0Kj=
lZpPnktMkJ7iNOxrrl0-3D GenericFile
200807 - Verwerving en vervreemding van eigen aandelen (https://u7061146.ct=
.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B=
6enPgwI16r40kJldvOc0ErQ7NH7eVKMS0DLzp20I5rFBLfOEYsLIurScd2AKMJ50yoY-3DfKr4_=
xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2F=
BZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdyla=
G89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfB=
FI1nghO7J6FqyanF5Z-2FPDqW0gf9D5Z7Izc6oQVb6f9-2FB-2F0VABqgRAdGq6KIoJy48ICqFG=
2gOwzb4rmQlfsAEfspsaErIvb1P2MRrPcZLXeKQDC5cu2wDDFbeFQdxtOcUB0VpEHaQ5nEgNKpU=
TSluaf3VdQ-3D GenericFile
200807 - UCB Acquisitions Disposals of own shares (https://u7061146.ct.send=
grid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6enPg=
wI16r40kJldvOc0ErQ7BTcHI-2BEwmdBo97YJuE1qjT71y2S0tYxeoPkMdDIDXxk-3DKwkZ_xDP=
ID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZl=
GB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdylaG89=
YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfBFI1=
nh23nrW0E-2BE1lR-2BLTL-2BZqYzfFqFSqjK4ffVFVsKlGm66zJqC3IwVQN9-2B6g4p97zSEjl=
ngv21Z3fktAmFnzKECsgMmSZAvNu2NGObw1BRePq3-2FY2SJCe50kGqmQ-2B5pXvUFFasHeRHFA=
yfQRhSCsV1FXM-3D GenericFile
200807 - Rachat et alie nation d actions propres (https://u7061146.ct.sendg=
rid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6enPgw=
I16r40kJldvOc0ErQ7tOeIwi0Ot2zBpPTJT-2FnqPqq6I7Ng-2BjU0iw4Bpf7CBHY-3DCxju_xD=
PID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZ=
lGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5-2F91sIdylaG8=
9YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4LjF-2FvwnJfBFI=
1nqeOAXUujxePXqsrt9CtoZEU7mRecfmxppYX-2Foc8jQMizN9y-2B5VC52M3jmSJQQ5eRMV5dz=
OFZMaUw257Ubt0bDD5yYVvENbLQFfeDP06O63-2FTg3YDthnEWsTWHnQFm1eUjz-2Fbc4xtjzFx=
23gT0ydeLs-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcX5Knczne2LXrrmaskUn8o38a9DOBB7Re=
oTYcY-2BBlsKpRYNzAzF15XytkFOcTKqfXwrFlKs9b8KudEL9fQY8bRM98rwAOTh9HdWnDWPSKQ=
BNc-3DaGtH_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6=
EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waVZEDZN9uqgGG1KVL4B2sVAUtj5=
-2F91sIdylaG89YV7aj8mVMA-2BQbj8-2F-2F4P4AuZKHCeAb2TaDI4FJGsXO5xZnqqucr5Jk4L=
jF-2FvwnJfBFI1nvyR9sRmEYs5kG-2BM9g5zhINzryYJcrPzZV-2BhDPfvhWZrriyMd1kOTxUfc=
V3JlbpnKcqteGBrxYYs1gsrM7kb2B0JcydcUQnSmx2kr3nbMzmdY0Tp-2FjyTVsc2PH5ZueS7fO=
oOTzV1fcR-2B47dx1JZz3rk-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=